Moreover, TEX-bound PD-L1 from HNSCC was able to reduce migration of CD4+ and CD8+ T-cells toward the tumor site, reducing the pressure of the immune response on tumoral cells [71]. This evidence concerns the gene CD8A and head and neck squamous cell carcinoma.